arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2511.11065cs.CVcs.AI

从视网膜像素到患者:糖尿病视网膜病变筛查中的深度学习研究演进

From Retinal Pixels to Patients: Evolution of Deep Learning Research in Diabetic Retinopathy Screening

Fraunhofer IAIS - Department of Media Engineering, Germany(弗劳恩霍夫研究所媒体工程部门);University of Bonn - Department of Computer Science, Germany(波恩大学计算机科学系);University Hospital Bonn - Department of Ophthalmology, Germany(波恩大学医院眼科部门);Lamarr Institute for Machine Learning and Artificial Intelligence, Germany(拉马尔人工智能与机器学习研究所)

Muskaan Chopra, Lorenz Sparrenberg, Armin Berger, Sarthak Khanna, Jan H. Terheyden, Rafet Sifa

AI总结:

本文系统性综述2016-2025年糖尿病视网膜病变筛查的深度学习研究进展,梳理技术方法、现存挑战,提出可临床落地的DR AI发展路线,相关成果可推广至大规模医学影像领域。

摘要:

糖尿病视网膜病变(DR)仍是可预防性失明的主要病因,早期检测对减少全球范围内的视力损失至关重要。过去十年间,深度学习变革了DR筛查领域,技术路径从基于私有数据集训练的早期卷积神经网络,逐步发展为可解决类别不平衡、标签稀缺、域偏移及可解释性问题的先进处理流水线。本综述首次系统性整合了2016至2025年间的DR研究,汇总了50余项研究、20余个数据集的成果。我们严谨梳理了自监督与半监督学习、域泛化、联邦训练、混合神经符号模型等方法进展,同时分析了评估协议、报告规范及可复现性挑战。基准表格呈现了跨数据集的性能表现,讨论部分重点指出多中心验证与临床信任方面的现存缺口。本研究通过关联技术进展与落地转化障碍,提出了构建可复现、隐私保护且可临床部署的DR AI的实践路线。除DR领域外,本次调研涉及的诸多创新可广泛推广至大规模医学影像场景。

英文摘要:

Diabetic Retinopathy (DR) remains a leading cause of preventable blindness, with early detection critical for reducing vision loss worldwide. Over the past decade, deep learning has transformed DR screening, progressing from early convolutional neural networks trained on private datasets to advanced pipelines addressing class imbalance, label scarcity, domain shift, and interpretability. This survey provides the first systematic synthesis of DR research spanning 2016-2025, consolidating results from 50+ studies and over 20 datasets. We critically examine methodological advances, including self- and semi-supervised learning, domain generalization, federated training, and hybrid neuro-symbolic models, alongside evaluation protocols, reporting standards, and reproducibility challenges. Benchmark tables contextualize performance across datasets, while discussion highlights open gaps in multi-center validation and clinical trust. By linking technical progress with translational barriers, this work outlines a practical agenda for reproducible, privacy-preserving, and clinically deployable DR AI. Beyond DR, many of the surveyed innovations extend broadly to medical imaging at scale.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑